tradingkey.logo

Quipt Home Medical Corp

QIPT
3.560USD
-0.005-0.14%
Close 02/06, 16:00ETQuotes delayed by 15 min
154.66MMarket Cap
LossP/E TTM

Quipt Home Medical Corp

3.560
-0.005-0.14%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Quipt Home Medical Corp

Currency: USD Updated: 2026-02-06

Key Insights

Quipt Home Medical Corp's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 61 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 3.10.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Quipt Home Medical Corp's Score

Industry at a Glance

Industry Ranking
61 / 75
Overall Ranking
334 / 4521
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Quipt Home Medical Corp Highlights

StrengthsRisks
Quipt Home Medical Corp. provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. The Company's expertise spans across a full spectrum of respiratory care, providing an end-to-end solution for medical providers and patients. This includes technology enabled equipment offerings and specialized care for patients with cardio and pulmonary diseases, sleep disorders, mobility challenges, and other chronic disease management. The Company's healthcare products and services include sleep apnea and pap treatment, home medical equipment, home ventilation and custom mobility solutions. It has a 60% ownership interest in Hart Medical Equipment, which maintains strategic relationships with integrated health systems and freestanding community-based hospitals, embedding the business into the hospital discharge processes of more than 19 hospitals and affiliated care facilities across its network.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 15.91% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 245.36M.
Fairly Valued
The company’s latest PE is -14.40, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 22.04M shares, decreasing 23.46% quarter-over-quarter.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.43.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
3.100
Target Price
-13.04%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Quipt Home Medical Corp is 6.26, ranking 63 out of 75 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 68.31M, representing a year-over-year increase of 29.80%, while its net profit experienced a year-over-year increase of 14.15%.

Score

Industry at a Glance

Previous score
6.53
Change
-0.27

Financials

6.60

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

3.47

Operational Efficiency

8.14

Growth Potential

5.94

Shareholder Returns

7.16

Quipt Home Medical Corp's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Quipt Home Medical Corp is 6.92, ranking 40 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is -14.40, which is -3260.98% below the recent high of 455.24 and -405.53% above the recent low of -72.81.

Score

Industry at a Glance

Previous score
6.92
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 61/75
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Quipt Home Medical Corp is 7.33, ranking 44 out of 75 in the Healthcare Providers & Services industry. The average price target is 3.10, with a high of 4.50 and a low of 1.70.

Score

Industry at a Glance

Previous score
7.33
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
3.100
Target Price
-13.04%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

67
Total
7
Median
9
Average
Company name
Ratings
Analysts
Quipt Home Medical Corp
QIPT
3
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
28
HCA Healthcare Inc
HCA
27
Tenet Healthcare Corp
THC
24
Universal Health Services Inc
UHS
23
1
2
3
...
14

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Quipt Home Medical Corp is 3.76, ranking 70 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 3.60 and the support level at 3.54, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
3.84
Change
-0.08

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.057
Neutral
RSI(14)
67.959
Neutral
STOCH(KDJ)(9,3,3)
24.873
Neutral
ATR(14)
0.024
Low Volatility
CCI(14)
-121.429
Sell
Williams %R
80.000
Sell
TRIX(12,20)
0.223
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
3.565
Sell
MA10
3.573
Sell
MA20
3.575
Sell
MA50
3.270
Buy
MA100
2.882
Buy
MA200
2.488
Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

Score

Industry at a Glance

Previous score
5.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Forager Capital Management, LLC
4.20M
--
Crawford (Gregory John)
4.59M
+14.50%
Claret Asset Management Corporation
3.96M
-6.53%
Lakeview L.L.C
3.47M
--
Kanen Wealth Management, LLC
1.72M
-10.78%
First Manhattan Co. LLC
1.65M
--
The Vanguard Group, Inc.
Star Investors
1.74M
--
Mehta (Hardik)
1.16M
+46.29%
1
2

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Quipt Home Medical Corp is 2.64, ranking 62 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.56. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
2.64
Change
0
Beta vs S&P 500 index
0.56
VaR
+4.49%
240-Day Maximum Drawdown
+49.09%
240-Day Volatility
+75.40%

Return

Best Daily Return
60 days
+34.10%
120 days
+34.10%
5 years
+53.41%
Worst Daily Return
60 days
-2.87%
120 days
-7.69%
5 years
-21.60%
Sharpe Ratio
60 days
+2.39
120 days
+2.06
5 years
+0.04

Risk Assessment

Maximum Drawdown
240 days
+49.09%
3 years
+80.68%
5 years
--
Return-to-Drawdown Ratio
240 days
+0.71
3 years
-0.18
5 years
--
Skewness
240 days
+4.53
3 years
+3.73
5 years
+3.33

Volatility

Realised Volatility
240 days
+75.40%
5 years
--
Standardised True Range
240 days
+3.13%
5 years
--
Downside Risk-Adjusted Return
120 days
+552.16%
240 days
+552.16%
Maximum Daily Upside Volatility
60 days
+74.35%
Maximum Daily Downside Volatility
60 days
+71.76%

Liquidity

Average Turnover Rate
60 days
+1.37%
120 days
+1.70%
5 years
--
Turnover Deviation
20 days
+143.08%
60 days
+80.99%
120 days
+124.79%

Peer Comparison

Healthcare Providers & Services
Quipt Home Medical Corp
Quipt Home Medical Corp
QIPT
5.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ensign Group Inc
Ensign Group Inc
ENSG
8.69 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Encompass Health Corp
Encompass Health Corp
EHC
8.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Quest Diagnostics Inc
Quest Diagnostics Inc
DGX
8.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cigna Group
Cigna Group
CI
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Labcorp Holdings Inc
Labcorp Holdings Inc
LH
8.44 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI